What's happened
Recent research finds limited evidence supporting medical cannabis for mental health conditions like anxiety, depression, or PTSD. The largest review to date shows cannabis is ineffective for many disorders and may worsen some, such as cocaine cravings. Promising results for autism, insomnia, and Tourette’s require further study.
What's behind the headline?
The study’s findings sharply contrast with public perceptions and policy trends favoring cannabis for mental health. The evidence indicates that cannabis offers no benefit for bipolar disorder, anxiety, ADHD, OCD, anorexia, or psychosis. Its use for depression remains unsupported, and it may exacerbate cravings in cocaine dependence. The only notable exception is cannabis use disorder, where cannabis-based treatments combined with therapy show promise.
This suggests that widespread medical cannabis use for mental health is not justified and could be harmful, especially without proper clinical oversight. The findings also raise concerns about delaying effective treatments, as patients might rely on cannabis instead of proven therapies. The potential for cannabis to worsen psychotic symptoms and foster dependency underscores the need for cautious policy and clinical guidance.
While some preliminary evidence hints at benefits for autism, insomnia, and Tourette’s, the low quality of evidence warrants further rigorous research. Overall, the study emphasizes that current evidence does not support routine cannabis use for mental health, and policymakers should reconsider existing approvals and guidelines.
What the papers say
The New York Times highlights that the study, led by Dr. Jack Wilson, analyzed 54 trials and found no benefit of cannabis for conditions like bipolar disorder, anxiety, or depression, and warned about potential harms such as increased cravings and delayed effective treatments. Alice Callahan’s article discusses anecdotal cases where diet, specifically the ketogenic diet, has helped some with mental health symptoms, but experts caution against replacing proven therapies. The NY Post reports on cannabis hyperemesis syndrome (CHS), linking severe vomiting episodes to heavy vaping of THC-rich cannabis, especially among daily users, and notes the disorder’s recent recognition by health authorities. These contrasting perspectives underscore the complexity of cannabis’s role in mental health and public health, with scientific evidence increasingly questioning its benefits and highlighting potential risks.
How we got here
Over the past decades, many US states and countries have legalized medical cannabis, driven by anecdotal reports of mental health benefits. However, scientific evidence has been inconsistent, with some studies suggesting benefits for epilepsy and pain, but limited data on mental health conditions. This new comprehensive review analyzes 54 trials from 1980 to 2025, challenging the assumption that cannabis is a mental health remedy.
Go deeper
More on these topics